MicroRNA-155 and antiviral immune responses

To‐Ha Thai, Dinis Pedro Calado, Stefano Casola, K. Mark Ansel, Changchun Xiao, Yingzi Xue, Andrew Murphy, David Frendewey, David M. Valenzuela, Jeffery L. Kutok, Marc Schmidt‐Supprian, Nikolaus Rajewsky, George D. Yancopoulos, Anjana Rao, Klaus Rajewsky

Article2007

The Atg5–Atg12 conjugate associates with innate antiviral immune responses

Nao Jounai, Fumihiko Takeshita, Kouji Kobiyama, Asako Sakaue-Sawano, Atsushi Miyawaki, Ke-Qin Xin, Ken J. Ishii, Taro Kawai, Akira Shizuo, Koichi Suzuki, Kenji Okuda

Proceedings of the National Academy of Sciences

Article2012

MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis

Maarten F. Corsten, Anna Papageorgiou, Wouter Verhesen, Paolo Carai, Morten Lindow, Susanna Obad, Georg Summer, Susan L. Coort, Mark R. Hazebroek, Rick van Leeuwen, Marion J. Gijbels, Erwin Wijnands, Erik A.L. Biessen, Menno P.J. de Winther, Frank Stassen, Peter Carmeliet, Sakari Kauppinen, Blanche Schroen, Stéphane Heymans

Article2012

Absence of microRNA‐155 protects against pressure overload‐induced cardiac inflammation and failure

Blanche Schroen, Maarten F. Corsten, Ben Janssen, Esther E. Creemers, Yigal M. Pinto, Serena Zacchigna, Mauro Giacca, Elena Vigorito, Thomas Thum, Peter Carmeliet, Manuel Mayr, León J. De Windt, Esther Lutgens, Menno P.J. de Winther, Anna Papageorgiou, Stéphane Heymans

Article2006

MicroRNA-155 Regulates Human Angiotensin II Type 1 Receptor Expression in Fibroblasts

Mickey M. Martin, Eun Joo Lee, Jessica A. Buckenberger, Thomas D Schmittgen, Terry S. Elton